BOTHELL, Wash. and MELVILLE, N.Y., Dec. 21 /PRNewswire-FirstCall/ -- Cardiac Science Corporation, , a leading provider of cardiac monitoring, defibrillation and rehabilitative products, and Henry Schein Medical Systems, the medical software division of Henry Schein, Inc., announced that the connection with HeartCentrix(R) ECG informatics system by Cardiac Science is complete. This connectivity enables the seamless transfer of Burdick(R) and Quinton(R) brand ECG, exercise stress and Holter monitoring results to version 5.0 of Henry Schein Medical Systems' electronic medical record (EMR) software, MicroMD(R) EMR.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)
The connection between Cardiac Science devices and MicroMD EMR will help physicians simplify diagnostic cardiology workflow in their offices by eliminating a source of data transcription errors, and will provide the physician a unified view of patient diagnostic data. With HeartCentrix ECG informatics, physicians have immediate access to electronically view or edit patients' test results and later retrieve data in MicroMD EMR.
"By integrating MicroMD EMR and HeartCentrix ECG informatics, we provide a means by which MicroMD EMR users can improve their efficiency by connecting their Quinton and Burdick devices directly to their EMR," said Greg Newman, director, product management, Cardiac Science Corporation. "Physicians using MicroMD EMR can seamlessly integrate cardiac tests from Burdick and Quinton branded devices to significantly improve the test-ordering and reviewing workflow. By eliminating paper and manual test results transfer, costs and chances for error are reduced."
"MicroMD EMR streamlines workflow, improves data accuracy and increases physician productivity," said Ajit Kumar, Ph.D., general manager, Henry Schein Medical Systems. "The new connectivity with HeartCentrix ECG informatics will now enable users of MicroMD EMR 5.0 to view and store test results from Burdick and Quinton products with a quick click of the mouse, allowing for faster and more confident diagnoses."
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor defibrillators and cardiology data management systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance and support services. The successor to various entities that owned and operated cardiac businesses under the trusted Burdick(R), Powerheart(R), Quinton(R) and HeartCentrix(R) brand names, Cardiac Science is headquartered in Bothell, WA, and has operations in California and Wisconsin, China, Denmark, France and the United Kingdom.
Frost & Sullivan, the global growth consulting company, awarded Cardiac Science its 2007 award for Global Excellence in ECG Monitoring, recognizing Cardiac Science's superior leadership and vision to provide superior healthcare solutions in the cardiac monitoring market.
About Henry Schein Medical Systems and Henry Schein, Inc.
More than 10,000 physicians in approximately 2,000 primary care and major specialty practices rely on MicroMD software from Henry Schein Medical Systems to streamline and simplify their business operations and clinical workflow, deliver high-quality care to patients and grow their practices. MicroMD PM is a proven, full-featured practice management system, rated #1 for user satisfaction by the Professional Association of Health Care Office Management and consistently ranked among the "Best in KLAS." MicroMD EMR is an intuitive, flexible electronic medical records system based on specialty-specific clinical workflows. MicroMD(R) EMR Version 5.0 is a CCHIT Certified product for CCHIT Ambulatory EHR 2006. MicroMD(R) PMR, a comprehensive system that combines and unites practice management and electronic medical records, maximizes practice efficiency and effectiveness. Henry Schein Medical Systems is a division of Henry Schein, Inc. For 75 years, Henry Schein has been dedicated to the success of office-based practitioners. For information, call 1-800-624-8832 or visit http://www.micromd.com.
Henry Schein, Inc. , a Fortune 500(R) company, is the largest distributor of healthcare products and services to office-based practitioners in the combined North American and European markets. Henry Schein's four business groups -- Medical, Dental, International and Technology -- serve more than 500,000 customers worldwide, including dental practices and laboratories, physician group practices and animal health clinics, as well as government and other institutions. The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 85,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available to our customers as special order items.
Henry Schein also offers a wide range of innovative value-added practice solutions for healthcare professionals, such as ArubA(R), the Company's electronic catalog and ordering system. Its leading practice management and EMR software solutions, including MicroMD(R) for medical practices, DENTRIX(R) and Easy Dental(R) for dental practices, and AVImark(R) for animal health clinics, have been installed in more than 50,000 practices.
Headquartered in Melville, N.Y., Henry Schein employs nearly 12,000 people and has operations in 19 countries. The Company's sales reached a record $5.05 billion in 2006. For more information, visit the Henry Schein Web site at http://www.henryschein.com.
"CCHIT(SM) and "CCHIT Certified(SM) are service marks of the Certification Commission for Healthcare Information Technology.
Forward Looking Statements
This press release contains forward-looking statements. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include those that infer or imply that the revenue and profits of Cardiac Science may increase as a result of the connectivity of its products with those of Henry Schein Medical Systems. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the 10-k filed by Cardiac Science Corporation for the year ended December 31, 2006 and other documents filed by Cardiac Science with the Securities & Exchange Commission. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
CONTACT: Mike Matysik, Senior Vice President and CFO of Cardiac Science
Corporation, +1-425-402-2009; or Investors, Douglas Sherk or Jenifer
Kirtland, +1-415-896-6820; or Media, Steve DiMattia, +1-646-201-5445, all
of EVC Group, Inc., for Cardiac Science Corporation; or Susan Vassallo,
Vice President, Corporate Communications of Henry Schein, Inc.,
+1-631-843-5562; or David Aquilina of Henry Schein Medical Systems,
+1-612-922-5551
Web site: http://www.cardiacscience.com/
http://www.henryschein.com/
